PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform

EMERYVILLE, Calif., Sept. 27, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding diversity of antibodies customers can discover on the Beacon® optofluidic platform. The new workflow…

Click here to view original post